SCIDNET website goes live

SCIDNET, a partnership initiative in which IPOPI is participating, has launched its new website
SCIDNET is an ambitious project, financially supported by the European Commission, aiming at developing genetic medicines for Severe Combined Immunodeficiency that can be licensed in the next 4 years.
IPOPI is participating so as to represent the views of patients with primary immunodeficiencies (PIDs). The initiative led by Prof Gaspar (University College of London) benefits from the participation of 10 partners representing leading university hospitals, associations and SME in Europe.

Press release